NYKAA welcomes Deepika Padukone as its brand ambassador. This partnership celebrates beauty’s evolving journey and reinforces that self-care is the best reason to get ready. Padukone, an actress, entrepreneur, and advocate, embodies timeless beauty. Together, NYKAA and Deepika Padukone inspire women to embrace self-love in a world of countless directions. The partnership aims to democratize beauty and empower millions.

Deepika Padukone’s Partnership

NYKAA has announced Deepika Padukone as their newest brand ambassador, effective September 25, 2025. This alliance signifies a celebration of personal beauty and self-expression, emphasizing that the best reason to get ready is for oneself.

NYKAA’s Vision

The collaboration with Deepika Padukone amplifies NYKAA’s commitment to empowering consumers and democratizing beauty across India. Deepika‘s authenticity and versatility align with NYKAA’s mission to transform beauty standards and inspire individuals to embrace their unique beauty journeys.

Deepika’s Perspective

Deepika Padukone stated that beauty has always been about everyday rituals and self-care practices. She emphasized that NYKAA understands this ethos, recognizing beauty not only for special occasions but also for everyday moments. Together, they aim to inspire millions to define beauty on their own terms.

Brand Initiatives

As brand ambassador, Deepika will participate in NYKAA’s key initiatives, including the Pink Friday Sale and the Nykaa Best in Beauty Awards. Her role extends beyond being a face of the brand; she embodies the message that beauty is individual and personal.

Source: BSE

Jupiter Electric Mobility (JEM), part of the Jupiter Group, has launched new 10 ft and 20 ft containerised Battery Energy Storage Systems (BESS). The first 10ft BESS will be supplied in partnership with GMMCO to Greenlit. These air-cooled systems range from 241 kWh to 3 MWh and support DG replacement, solar storage, and backup power. JEM will also export its first 20ft BESS unit to Africa in October.

New Battery Systems Launched

Jupiter Electric Mobility (JEM) has announced the launch of its new 10 ft and 20 ft containerised Battery Energy Storage Systems (BESS). The new product line was announced on September 25, 2025. JEM is partnering with GMMCO to supply the first 10ft BESS to Greenlit.

System Features & Specifications

The BESS are developed ground-up in JEM and features air-cooled, modular design with capacities ranging from 241 kWh to 3 MWh. These systems are engineered for easy transportation, robust performance in harsh conditions, and deployment across various applications, including diesel generator (DG) replacement, solar storage, energy shifting, and backup power for commercial and industrial use.

Expansion and Global Reach

JEM will export its first 20ft BESS unit to Africa in October and will soon launch liquid-cooled BESS systems for grid-scale usage. JEM’s Indore plant will scale from a capacity of 1 GWh annually to 5 GWh in the next 3 years to meet growing C&I and utility market demand.

Strategic Vision

JEM’s BESS portfolio addresses India’s evolving energy needs, focusing on DG replacement and solar storage, contributing to a resilient, sustainable, and low-carbon energy infrastructure.

Source: BSE

Kirloskar Oil Engines has received a Show Cause Notice regarding an ITC mismatch for FY 2021-22. The notice, dated September 24, 2025, was issued by the Deputy Commissioner of State Tax, Pune. The notice pertains to potential penalties and tax demand, but the company does not anticipate any material impact on its financial operations.

GST Notice Received

Kirloskar Oil Engines has been issued a Show Cause Notice concerning an Input Tax Credit (ITC) mismatch. The notice was received on September 24, 2025, from the Deputy Commissioner of State Tax, Pune.

Details of the Notice

The Show Cause Notice relates to a discrepancy in ITC for the financial year 2021-22. The notice includes a potential penalty of Rs. 1,34,41,427, interest amounting to Rs. 7,62,33,455, and a tax demand of Rs. 9,74,06,747.

Impact Assessment

The company is currently assessing the implications of the notice and is preparing a response. However, Kirloskar Oil Engines does not foresee any significant adverse effect on its financial condition, operations, or other business activities as a result of this matter.

Source: BSE

Abbott India announces the resignation of Mr. Munish Prashar, Plant Director – Goa, effective from the close of business hours on October 31, 2025. Mr. Prashar is leaving the company to pursue an external career opportunity. The company has confirmed that there are no other material reasons for his resignation.

Plant Director’s Departure

Abbott India Limited has announced that Mr. Munish Prashar, who held the position of Plant Director at the Goa facility, has tendered his resignation from the company. His last day will be October 31, 2025.

Reason for Resignation

Mr. Prashar’s resignation is driven by his decision to pursue an external career opportunity. He expressed gratitude for his time with Abbott, acknowledging the professional and personal growth he experienced over the past 5 years.

Leadership Transition

With his resignation effective October 31, 2025, Mr. Prashar will also cease to be part of the Senior Management Personnel of the company. Abbott India will now begin the process of identifying and appointing a successor to ensure a smooth transition of leadership at the Goa plant.

Source: BSE

The Debenture Allotment Committee of Rashtriya Chemicals and Fertilizers Limited approved the allotment of 39,500 Listed, Rated, Unsecured, Redeemable, Non-Cumulative, Taxable, Non-Convertible Debentures (NCDs), each with a face value of ₹1,00,000, aggregating to ₹395 crore. These debentures carry an interest rate of 7.60% and were allotted on a private placement basis. The meeting concluded on September 25, 2025.

Debenture Allotment Approval

Rashtriya Chemicals and Fertilizers Limited announced that its Debenture Allotment Committee, in a meeting held on September 25, 2025, approved the allotment of debentures. The announcement was made on the same day.

Details of the Allotment

The committee approved and allotted 39,500 debentures. These are 7.60% Listed, Rated, Unsecured, Redeemable, Non-Cumulative, Taxable, Non-Convertible Bonds. Each debenture has a face value of ₹1,00,000, bringing the total allotment to ₹395 crore (Rupees 395 crore).

Key Features of the Debentures

The debentures were issued through private placement. Key details include:

• Issuer: Rashtriya Chemicals and Fertilizers Limited
• Series Name: RCF Series II-2025
• Date of Allotment: September 25, 2025
• Face Value per NCD: ₹1,00,000
• Issue Price per NCD: ₹1,00,000
• Listing: To be listed on the WDM segment of BSE & NSE
• ISIN: INE027A08044
• Tenure: 3 years and 10 months
• Interest Rate: 7.60% p.a.
• Interest Payment: Annually
• Redemption Date: Wednesday, July 25, 2029
• Security: Unsecured
• Use of Proceeds: Augmentation of long-term working capital and capital expenditure.

Debenture Holders

The investors allotted debentures are:

• A. K. Capital services Limited: 5000
• HDFC bank Limited: 2500
• Nuvama wealth finance Limited: 3000
• Pnb Gilts Limited: 4000
• Reliance general insurance company Limited: 5000
• The Jammu and Kashmir Bank Limited: 10000
• UCO bank: 7500

Source: BSE

CARE Ratings has reaffirmed the credit ratings for Birlasoft’s bank facilities. The long-term bank facilities are rated CARE AA+; Stable, with an amount of ₹307.00 crore. Both long-term/short-term and short-term bank facilities are also reaffirmed at CARE AA+; Stable / CARE A1+ and CARE A1+ respectively. These ratings reflect Birlasoft’s established position and robust financial standing.

Credit Ratings Reaffirmed

CARE Ratings Limited has reaffirmed the ratings assigned to the bank facilities of Birlasoft. This decision reflects the company’s strong position in the IT services industry and its healthy financial risk profile.

Rating Details

The ratings for Birlasoft’s bank facilities are as follows:

• Long-term Bank Facilities: CARE AA+; Stable, Amount: ₹307.00 crore
• Long-term/Short-term Bank Facilities: CARE AA+; Stable / CARE A1+, Amount: ₹20.00 crore
• Short-term Bank Facilities: CARE A1+, Amount: ₹25.00 crore

Key Rating Drivers

The reaffirmation of Birlasoft’s ratings is supported by several factors:

• Established position in the IT services industry, particularly in MedTech, Cards & Payments, Asset Management, and ERP implementation services.
• Robust capital structure.
• Healthy cash flow generation.
• Strong liquidity with cash and liquid investments exceeding ₹1,900 crore as of March 31, 2025.
• Benefits from being part of the CKA Birla Group.

Financial Performance

In FY25, Birlasoft reported a decline in PBILDT margins by approximately 300 bps year-over-year due to a challenging demand environment in the USA. The company has a healthy order pipeline, with a total contract value of US$236 million. The company’s diversified service offerings and focus on digital, cloud, and AI capabilities provide medium-term revenue visibility.

Rating Sensitivities

Positive factors that could lead to an upgrade in the rating include:

• Significant improvement in scale of operations and geographical diversification.
• Ability to enhance operating profitability margins to 20% or more on a sustained basis.

Negative factors that could lead to a downgrade in the rating include:

• Incremental sizeable debt-funded acquisition that moderates capital structure.
• Slowdown in key verticals resulting in significant pressure on income and PBILDT margin falling below 12%.
• Major regulatory challenges impacting operations.

Outlook

The outlook on the ratings is ‘Stable,’ reflecting the expectation that Birlasoft’s financial risk profile will remain strong in the near-to-medium term, supported by its established business profile and healthy order book position.

Source: BSE

Natco Pharma’s Board of Directors has given in-principle approval to evaluate the demerger of its Agro business. The demerger aims to unlock the core business value of pharmaceuticals, enhance long-term growth, and provide operational flexibility. The company may retain a small minority stake in the resulting entity, supporting common services. The board has authorized management to evaluate the proposed demerger and consider optimal capital structure.

Agro Business Demerger

Natco Pharma’s Board has approved evaluating the demerger of its Agro business as of September 25, 2025. This decision is aimed at creating enhanced value and operational efficiency.

Strategic Rationale

The primary goal of this demerger is to unlock value in the core pharmaceutical business and enable long-term growth. By separating the Agro business, Natco Pharma expects to achieve more focused management and improved brand positioning for both entities.

Operational Restructuring

The demerger is expected to provide greater operational flexibility, allowing for more dedicated management of each business segment. Post-demerger, the company may retain a small minority stake in the resulting Agro business to support common services like R&D and patents.

Next Steps

The management is authorized to undertake a detailed evaluation of the proposed demerger, including suggesting an optimal capital and shareholding structure. Consultants and advisors will be appointed to evaluate the transaction and ensure progress. The Board will consider the matter and give approval at a later date.

Source: BSE